Gene Therapy Net Newsletter |
|

|
News: UK biotech AlveoGene launches with plans for inhaled gene therapy
|
|
The company aims to capitalize on research by the Respiratory Gene Therapy Consortium, and is working first on a treatment of alpha-1 antitrypsin deficiency. The unusual approach could be a way to more reliably deliver gene therapies directly to the epithelial cells of the lungs. The company said preclinical research suggests its technology — dubbed InGenuiTy — could work with high efficiency and long-lasting effects. AlveoGene aims to bring its first candidate, a treatment for patients with alpha-1 antitrypsin deficiency or AATD, into clinical testing over the next two to three years. The company said it will also look to combine its platform with other technologies to target additional diseases such as lung surfactant deficiencies and idiopathic pulmonary fibrosis.
Read more…
|
|
|
Conference: 2nd Aseptic BioPharma Processing Summit
|
|
Staying updated on regulatory requirements is crucial for ensuring compliance and maintaining the highest quality standards in drug manufacturing. The new EU GMP Annex 1 was officially published and came into effect in August 2023. The 2nd Aseptic BioPharma Processing Summit (November 9-10) features comprehensive coverage on the implementation and management of the latest knowledge in aseptic, barrier, containment, and aseptic best practice technologies along with environmental monitoring systems, facility cleaning and disinfectant qualification, cleanroom operations, filtration, sterilization, and aseptic process simulation or media fill. This two-day summit encompasses expert insight into the robust aseptic processing requirements facing the industry as well as delving into more focus on the ever-growing rise of advanced therapies from allogenic cell therapies to innovative fill-finish lines.
Register now…
|
|
|
Conference: Advanced Purification for Complex Biologics Summit
|
|
The Advanced Purification for Complex Biologics Summit (November 28-30) is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines.
This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and digital learning tools to help you save time during downstream processing and boost efficiency.
This is your unique opportunity to meet 60+ purification and downstream processing experts including Sanofi, Takeda, Eli Lilly, AstraZeneca and Regeneron as they talk you through machine learning, predictive modelling, and consumables advancements to empower your process optimization, moving a step closer to 100% product purity. Register now…
|
|
|
Conference: Cell Therapy for Autoimmune Disease Summit
|
|
The Cell Therapy for Autoimmune Disease Summit (November 28-30) is an unparalleled, pioneering event that unites leading experts and stakeholders in this exciting emerging field. This groundbreaking summit serves as a platform for sharing and discussing latest advances in pre-clinical, translational, and clinical development across various cell types including CAR-T, Tregs and MSCs.
Register now…
|
|
|
Conference: Donor Selection & Cell Source Summit
|
|
The inaugural Donor Selection and Cell Source Summit (November 28-30) is the pioneering forum for cell therapy leaders within process development, supply chain, procurement, R&D and analytics, placing a spotlight focus on cell source starting material for the first time. Get caught up to speed on this dynamic space with expertise shared from the likes of Allogene, Caribou Bio, Poseida Therapeutics, and many others as these titans of industry unite to help you advance your knowledge on donor selection, management and sustainability to ensure a consistent and reliable supply of cell source material required for clinical trials and beyond.
Register now…
|
|
|
Conference: 4th Annual CRISPR 2.0 Congress
|
|
The industry-leading, industry-focused forum for showcasing the latest and greatest CRISPR tools being developed and exploring how this expanding CRISPR toolbox is being applied in the therapeutic setting. Across 3 days of keynote plenaries, new data readouts, and focused group discussions, hear from and engage with the likes of CRISPR Therapeutics, Editas Medicine, Caribou Biosciences, Prime Medicine, the Doudna Lab, and 70+ other leading drug developers, academic institutes, and leading service providers. Enabling in-depth presentations and focused group discussions, for the first this time, CRISPR 2.0 (November 28-30) will have 2 dedicated tracks of content this year:
- Technology Innovation: Showcasing the most innovative discovery, R&D, and platforms from 2023
- Translating to the Clinic: Levelling up strategy to progress through late preclinical, IND, and early clinical stages
As well as leveraging insights from these talks and panels – engage in stimulating discussions, hands-on workshops, and leverage 7+ hours of networking opportunities with your peers to foster collaboration and spark ground-breaking ideas. Register now…
|
|
|
Conference: 5th Cell Therapy Analytical Development Summit
|
|
Returning for the 5th year, the Cell Therapy Analytical Development Summit will unite technical leaders to better characterize potency, safety, viability, and sterility across early and late-stage analytical development for oncology & regenerative medicine. Join industry leaders from the like of Takeda, Bristol Myers Squibb, Novartis, Merck, Kite, and more this December 4-6 in Boston!
Register now…
|
|
|
Conference: 3rd Synthetic Biology-Based Therapeutics Summit
|
|
Gain valuable insights at the 3rd Synthetic Biology-Based Therapeutics Summit (December 4-6) on logic gating, AI-driven protein design, enhanced gene engineering, and the groundbreaking world of engineered biology from our expert speaker faculty including Arsenal Bio, Synlogic, Senti Bio, Gingko Bioworks, Merck, Strand Therapeutics and many more. Download the event guide to get details on the line-up.
Register now…
|
|
|
Conference: Cell & Gene Therapy Manufacturing & Commercialization Europe
|
|
Save the date to the upcoming Cell & Gene Therapy Manufacturing & Commercialization Europe event that occurs on 4-7 December at the Convention Centre Dublin! This year join 400+ global attendees, 50+ exhibitors, and 60+ industry-leading speakers to learn the latest CGT manufacturing, commercialisation & analytical strategies across our 3 conference tracks.
View our agenda and use the link below to save 10%! Register now…
|
|
|
Conference: mRNA Assay Development Summit
|
|
The mRNA Assay Development Summit (December 6-7) is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development. With key industry experts leading the speaker faculty, you will gain essential knowledge to fast-track mRNA therapeutics and vaccines into the clinic and towards approval. Join 60+ industry experts, including Moderna, Sanofi, Beam Therapeutics and more this December!
Register now…
|
|
|
Conference: 2nd Annual LNP Immunogenicity & Toxicity Summit
|
|
Back for its second iteration, the LNP Immunogenicity & Toxicity Summit (December 11-13) will bring together 100+ PKPD, Immunology, Safety, Toxicology experts from biopharma and academia to share best practice and address the next wave of challenges. With a unique agenda designed specifically on the hottest topics requested from the industry experts, this is your opportunity to analyze your LNP with precise PKPD, biodistribution, immune response for applications in gtx therapy, vaccination and much more. You will leave with a deeper understanding of the innovative work going on to developing robust safety profiles and deepen your knowledge on novel LNP based therapeutics, as well as multiple case studies which outline strategic and technical conducts.
Register now…
|
|
|
Conference: Gene Therapy Process Development Summit
|
|
The inaugural Gene Therapy Process Development Summit (December 13-14) is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are manufactured repeatably, at scale, and in a cost-effective manner.
Join us in Philadelphia this December to discover and learn the latest insights through case study presentations, informative panel discussions, and deep-dive workshops from Ultragenyx, REGENXBIO, Janssen, Amgen, Astellas Gene Therapies, and many more!
Whether you are looking to improve your platform processes or shorten development timelines this summit will be a unique opportunity to meet and network with peers to discuss successes and challenges in your process development journeys.
Register now…
|
|
|
Upcoming conferences and meetings
|
|
- 17 – 19 October 2023 - 2nd Innate Killer Europe Summit - London, UK
- 17 - 19 October 2023 - 2nd Lipid Nanoparticle Development Europe Summit - Amsterdam, The Netherlands
- 18 – 19 October 2023 - World Drug Safety Congress Americas 2023 - Boston, MA
- 24 – 26 October 2023 - Gene Editing Delivery Summit - Boston, MA
- 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium
- 30 October - 1 November 2023 - TIDES Europe 2023 - Oligonucleotide and Peptide Therapeutics - Amsterdam
- 30 October - 1 November 2023 - CRISPR-Based Therapy Analytical Development Summit - Boston, MA
- 31 October - 2 November 2023 - 14th World Orphan Drug Congress Europe - Barcelona, Spain
- 6 - 9 November 2023 - 5th Gene Therapy for Neurological Disorders Summit - Boston, MA
- 7 - 8 November 2023 - Cell Series UK 2023 - London, UK
- 9 - 10 November 2023 - 2nd Aseptic BioPharma Processing Summit - Vienna, Austria
- 14 - 15 November 2023 - Precision Oncology Europe 2023 - Berlin, Germany
- 14 - 15 November 2023 - Biomarkers Europe 2023 - Berlin, Germany
- 16 - 17 November 2023 - Global Bioprocessing Summit - Gene & Cell Therapies - Berlin, Germany
- 27 - 30 November 2023 - 5th Annual Gene Therapy Analytical Development Summit 2023 - Boston, MA
- 28 - 29 November 2023 - International Bioprocessing and Biologics Forum - Berlin, Germany
- 28 - 30 November 2023 - Donor Selection & Cell Source Summit - Cell & Gene Therapies - San Francisco, CA
- 28 - 30 November 2023 - Cell Therapy for Autoimmune Disease Summit - Philadelphia, PA
- 28 - 30 November 2023 - Advanced Purification for Complex Biologics Summit - Philadelphia, PA
- 28 - 30 November 2023 - 4th Annual CRISPR 2.0 Congress - Boston, MA
- 4 - 6 December 2023 - Cell Therapy Analytical Development 2023 - Boston, MA
- 4 - 6 December 2023 - 3rd Synthetic Biology-Based Therapeutics Summit - Boston, MA
- 6 - 7 December 2023 - mRNA Assay Development Summit - Boston, MA
- 4 – 7 December 2023 - Cell & Gene Therapy Manufacturing & Commercialization Europe - Dublin, Ireland
- 11 - 13 December 2023 - 2nd Annual LNP Immunogenicity & Toxicity Summit - Boston, MA
- 13 - 14 December 2023 - Gene Therapy Process Development Summit - Philadelphia, PA
- 16 - 19 January 2024 - Advanced Therapies Week - Gene Therapies - Miami, FL
- 16 - 19 January 2024 - 23rd annual Peptalk conference - San Diego, CA
- 23 - 25 January 2024 - Gene Therapy Regulatory Affairs Summit - Boston, MA
- 7 - 8 February 2024 - 7th Annual Cell & Gene Therapy Innovation Leaders Summit 2024 - Barcelona, Spain
- 27 - 29 February 2024 - 7th CAR-TCR Summit Europe - London, UK
- 13 - 14 March 2024 - RNA Leaders Europe Congress - Boston, MA
- 8 - 11 May 2024 - American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - Baltimore, MD
- 3 - 7 June 2024 - 10th Monolith Summer Symposium – Monoliths, Gene Therapy, Vaccines - Portorož, Slovenia
- 24 - 27 October 2024 - 31th Annual Meeting of the European Society of Gene & Cell Therapy (ESGCT) - Rome, Italy
|
|
|
|